Corbus Pharmaceuticals Holdings Inc. Stock Slides 7.7%, Underperforms Peers

Dow Jones2026/10/14 20:33

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!

A welcome pack worth 6200 USDT for new users! Sign up now!

This article was automatically generated by Dow Jones using technology from Automated Insights.

Shares of Corbus Pharmaceuticals Holdings Inc. slid 7.7% to $4.41 on what proved to be an all-around grim trading session for the stock market, with the NASDAQ Composite Index falling 1.9% to 26,692.87 and Dow Jones Industrial Average falling 0.1% to 51,621.48.

This was the stock's third consecutive day of losses.

Corbus Pharmaceuticals Holdings Inc. closed 78.6% short of its 52-week high of $20.56, which the company achieved on October 20th.

The stock underperformed when compared to some of its peers, as Vanda Pharmaceuticals Inc. fell 1.9% to $4.22, Fortress Biotech Inc. fell 2.6% to $1.90, and Viking Therapeutics Inc. fell 4.43% to $25.47.

Trading volume totaled 1.3 million, compared to the 50-day average of 933,647.

Data source: Dow Jones Market Data, FactSet

(END) Dow Jones Newswires

October 14, 2026 16:33 ET (20:33 GMT)

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.

Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.

Trade now！

In September, Anthropic directly acquired Caterpillar equipment orders worth 3.4 billion USD, securing 1.7 GW of gas generator units, marking the largest single purchase of power generation equipment in AI history. This move bypassed utility middlemen, capturing scarce capacity at prices set years ago with near-term delivery. It is part of Anthropic's plan to invest over 895 billion USD in computing infrastructure by 2045.

华尔街见闻•2026/11/08 12:41